Disease & disorder
breast neoplasm
MONDO:0021100
A benign or malignant neoplasm of the breast parenchyma. It can originate from the ducts, lobules or the breast adipose tissue. Breast neoplasms are much more common in females than males.
Research intelligence
Directly mapped studies only · unique clinical trialsCurrent registry observations. Phase counts may overlap. Study start dates are not registry registration dates. Investigational interventions are not approved-treatment recommendations.
Medications under investigation
Verified disease and drug mappings that co-occur within the same study; not evidence of effectiveness.
Loading mapped interventions…
MONDO disease family
Loading verified ontology relationships…
Recruiting studies by city
Loading research-site locations…
Trial status
Loading…
Trial phase
Loading…
Study start year
Loading…
Investigated drug interventions
Loading…
Clinical trials
40 shownTRAIL-R2 and HER2 Bi-Specific Chimeric Antigen Receptor (CAR) T Cells for the Treatment of Metastatic Breast CancerNCT06251544 · 2026-08-03
RECRUITINGEvaluating an AI-Based Mobile Application for Chemotherapy Support in Breast Cancer PatientsNCT07273812 · 2026-06-01
RECRUITINGSurviving Daily LifeNCT07054723 · 2025-10-02
RECRUITINGImproved Successful Retrieval Rate of HydroMARK Plus Breast Biopsy Site Marker in Comparison to HydroMARK as Well as Improved Surgeon SatisfactionNCT06294574 · 2025-08-05
RECRUITINGCRYoablation for Small Tumors As Local Treatment - SIX TrialNCT06839001 · 2025-03-01
RECRUITINGHealth Economic Evaluation of an Adapted Physical Activity Program for Women With Breast CancerNCT05949983 · 2024-12-23
RECRUITINGA Prospective Study to Develop and Clinically Validate an in Vitro Diagnostic Medical Device That Uses Blood to Classify Patients at High Risk for Breast CancerNCT06672302 · 2024-10-16
RECRUITINGTart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced NeuropathyNCT06268665 · 2024-08-15
RECRUITINGEvaluating the Impact of Financial Navigation on Financial Catastrophe and Distress for Cancer CareNCT06630962 · 2024-07-15
RECRUITINGSacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM)NCT05465031 · 2024-04-17
RECRUITINGIIT2023-09-Chung-UpfrontTAD: Upfront TAD/SNB in Patients With Breast Cancer With Nodal MetastasesNCT06092892 · 2024-04-07
RECRUITINGCryoablation vs Lumpectomy in T1 Breast CancersNCT05505643 · 2024-04-03
RECRUITINGTCM Therapy Program Impact on Breast Cancer Patients' Vital EnergyNCT06337214 · 2024-03-13
RECRUITINGStudy of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.NCT06072612 · 2023-12-05
RECRUITINGRepeat Breast Conserving Surgery Followed by Daily Partial Breast Irradiation in Ipsilateral BreastNCT06129747 · 2023-11-30
RECRUITINGA Study of Oral MBQ-167 in Participants With Advanced Breast CancerNCT06075810 · 2023-11-09
RECRUITINGPredicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 StudyNCT06805812 · 2023-05-01
RECRUITINGCorrelation of Clinical Response to Pathologic Response in Patients With Early Breast CancerNCT05020860 · 2023-04-18
RECRUITINGImproving Lifestyle Behavior by "Joven, Fuerte y Saludable" Multidisciplinary Program.NCT06090747 · 2023-03-09
RECRUITINGSNF Platform Study of HR+/ HER2-advanced Breast CancerNCT05594095 · 2022-12-30
RECRUITINGFudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant TherapyNCT05582499 · 2022-11-01
RECRUITINGBreast Cancer Long-term Outcomes on Cardiac Functioning: a Longitudinal StudyNCT05851053 · 2022-09-01
RECRUITING3D Ultrasound Breast ImagingNCT04692818 · 2021-11-10
RECRUITINGMolecular Breast Imaging Guidance for Breast Biopsy for Patients With Breast AbnormalitiesNCT06058650 · 2021-08-26
RECRUITINGTherapeutic Education and Nursing Support Program for Supportive Care, in Patients Treated With Hormone Therapy for Non-metastatic Breast CancerNCT04794075 · 2021-08-09
RECRUITINGAxillary Management in Breast Cancer Patients With Needle Biopsy Proven Nodal Metastases After Neoadjuvant ChemotherapyNCT04109079 · 2021-02-26
RECRUITINGPreventing Chemotherapy-induced Peripheral Neuropathy Using PRESIONA Exercise ProgramNCT04652609 · 2021-01-01
RECRUITINGMagnetic Marker Localization for Occult Breast Cancer and Target Axillary Dissection in Node-positive Breast Cancer Post-neoadjuvant ChemotherapyNCT05427071 · 2020-10-15
RECRUITINGPHOENIX DDR/Anti-PD-L1 Trial: A Pre-surgical Window of Opportunity and Post-surgical Adjuvant Biomarker Study of DNA Damage Response Inhibition With or Without Anti-PD-L1 Immunotherapy in Patients With Neoadjuvant Treatment Resistant Residual Triple Negative Breast CancerNCT03740893 · 2019-10-15
RECRUITINGQuantitative Microvasculature Imaging for Breast Cancer Detection and MonitoringNCT04799535 · 2019-09-01
RECRUITINGThe MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac StudyNCT04075305 · 2019-02-01
RECRUITINGMetastatic Breast Cancer in AustriaNCT03870620 · 2015-06-15
RECRUITINGPhase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast CancerNCT01766297 · 2013-02-01
RECRUITINGMolecular Breast Imaging (MBI)-Guided BiopsyNCT07114679 · 2027-06-01
NOT_YET_RECRUITINGTrial to Evaluate the Impact of Various Pragmatic Interventions to Increase Mammography Uptake Among Defaulted Repeat Screeners in SingaporeNCT07651345 · 2026-03-09
ENROLLING_BY_INVITATIONKNUCH CadAI-B-1(KCB-1)NCT06622967 · 2024-09-15
UNKNOWNA Study of BRIA-OTS Cellular Immunotherapy in Metastatic Recurrent Breast CancerNCT06471673 · 2024-05-29
UNKNOWNEvaluating Investigational Medical Device for Breast Tumor Diagnosis Using Diffusion Optical SpectroscopyNCT06597175 · 2024-04-16
COMPLETEDStudy of Anxiety After a Session of Energy Resonance by Cutaneous StimulationNCT06056414 · 2024-01-08
COMPLETEDHOBBIT 3: Mental Exercises and Temporal AlterationNCT06100068 · 2023-11-27
COMPLETEDDrugs being studied
Research locations
HoustonTexas, United States13New YorkNew York, United States13BethesdaMaryland, United States12NashvilleTennessee, United States12DallasTexas, United States11Los AngelesCalifornia, United States9PhiladelphiaPennsylvania, United States9RochesterMinnesota, United States9BaltimoreMaryland, United States8LondonUnited Kingdom8MadridSpain8MiamiFlorida, United States8
Leading sponsors
Merck Sharp & Dohme LLC7National Cancer Institute (NCI)7Mayo Clinic6BriaCell Therapeutics Corporation4University of Pennsylvania4Chinese PLA General Hospital3Columbia University3G1 Therapeutics, Inc.3National University Hospital, Singapore3Nuvation Bio Inc.3UMC Utrecht3Universitaire Ziekenhuizen KU Leuven3University of Washington3Aga Khan University2Borstkanker Onderzoek Groep2
Disease identity and terminology: MONDO. Trial relationships: ClinicalTrials.gov.